Abstract
Heart failure is the leading cause of hospitalization in the USA. Despite major advances in the medical and device-related therapy including chronic resynchronization therapy for management of heart failure, significant number of patients eventually require advanced cardiac therapy including mechanical circulatory support or heart transplant. Heart transplant is a gold standard for end-stage heart failure but is limited by the donor heart shortage creating a definite need for alternative effective therapies. The earliest and most common form of mechanical circulatory support is counterpulsation therapy. Annually, more than 150,000 patients worldwide receive counterpulsation therapy for various indications including cardiogenic shock or severe left ventricular dysfunction (Nanas and Moulopoulos in Cardiology, 84:156–167, 1994) and many thousands of lives are saved each year (65 % survival) (Torchiana et al. in Journal of Thoracic and Cardiovascular Surgery, 113(4):758–764, 1997). There are different types of aortic counterpulsation devices. Here, we will give an overview of different counterpulsation devices with focus on C-Pulse device. Extra-aortic balloon counterpulsation, C-Pulse (Sunshine Heart Inc., Eden Prairie, MN), is an important and novel approach in the management of patients with advanced heart failure who remain symptomatic despite optimum medical and device-based therapy. C-Pulse is designed to provide permanent, long-term, continuous partial circulatory support for New York Heart Association class III and ambulatory class IV heart failure patients. C-Pulse is a nonblood-contacting counterpulsation using an inflatable cuff around the ascending aorta, extra-aortic balloon (EAB) counterpulsation device. A pivotal, multicenter US study to assess the safety and efficacy of C- Pulse in patient with Stage C and NYHA Class III or ambulatory Class IV heart failure is in progress.
Similar content being viewed by others
References
Nanas, J. N., & Moulopoulos, S. D. (1994). Counterpulsation: historical background, technical improvements, hemodynamic and metabolic effects. Cardiology, 84, 156–167.
Torchiana, D. F., Hirsh, G., Buckley, M. J., et al. (1997). Intraaortic balloon pumping for cardiac support: trends in practice and outcome, 1968 to 1995. Journal of Thoracic and Cardiovascular Surgery, 113(4), 758–764.
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., et al. (2005). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 112, e154–e235.
Lloyd-Jones, D., Adams, R. J., Brown, T. M., Carnethon, M., Dai, S., De Simone, G., et al. (2010). Executive summary: heart disease and stroke statistics—2010 update: a report from the American Heart Association. Circulation, 121, 948–954.
Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Adams, R. J., Berry, J. D., Brown, T. M., et al. (2011). Heart disease and stroke statistics—2011 update: a report from the American Heart Association. Circulation, 123, e18–e209.
Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., et al. (2012). Heart disease and stroke statistics—2012 update: a report from the American Heart Association. Circulation, 125, e2–e220.
The Captopril-Digoxin Multicenter Research Group. (1988). Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. JAMA, 259, 539–544.
Packer, M., Bristow, M. R., Cohn, J. N., et al. (1996). The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. New England Journal of Medicine, 334, 1349–1355.
The RALES Investigators. (1996). Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure. American Journal of Cardiology, 78, 902–907.
The SOLVD Investigators. (1991). Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. New England Journal of Medicine, 325, 293–302.
Kantrowitz, A. (1987). A moment in history: introduction of left ventricular assistance. ASAIO Journal, 10, 39.
Kantrowitz, A. (1953). Experimental augmentation of coronary flow by retardation of the arterial pressure pulse. Surgery, 34, 678–687.
Kantrowitz, A. (1959). The experimental use of diaphragm as an auxiliary ventricle. Surgical Forum, 9, 266.
Cochran, R. P., Starkey, T. D., Panos, A. L., et al. (2002). Ambulatory intraaortic balloon pump use as bridge to heart transplant. Annals of Thoracic Surgery, 74, 746–752.
Kantrowitz, A., Krakauer, J., Rubenfire, M., et al. (1972). Initial clinical experience with a new permanent mechanical auxiliary ventricle: the dynamic aortic patch. Transactions of the American Society for Artificial Internal Organs, 18, 159–167.
Trainini, J., Cabrera Fischer, E. I., Barisani, J., et al. (2002). Dynamic aortomyoplasty in treating end-stage heart failure. Journal of Heart and Lung Transplantation, 21, 1068–1073.
Cheung, A. T. S. J., & Weiss, S. J. (1996). Beat-to-beat augmentation of left ventricular function by intraaortic counterpulsation. Anesthesiology, 84, 545–554.
Cochran, R. P., Starkey, T. D., Panos, A. L., & Kunzelman, K. S. (2002). Ambulatory intraaortic balloon pump use as bridge to heart transplant. Annals of Thoracic Surgery, 74, 746–751. discussion 751-742.
Scheidt, S. W. G., Mueller, H., et al. (1973). Intra-aortic balloon counterpulsation in cardiogenic shock. New England Journal of Medicine, 288, 979–984.
Lefemine, A. A., Low, H. B., Cohen, M. L., Lunzer, S., & Harken, D. E. (1962). Assisted circulation. III. The effect of synchronized arterial counterpulsation on myocardial oxygen consumption and coronary flow. American Heart Journal, 64, 789–795.
Kern, M. J., Aguirre, F. V., Tatineni, S., Penick, D., Serota, H., Donohue, T., et al. (1993). Enhanced coronary blood flow velocity during intraaortic balloon counterpulsation in critically ill patients. Journal of the American College of Cardiology, 21, 359–368.
Ishihara, M., Sato, H., Tateishi, H., Kawagoe, T., Muraoka, Y., & Yoshimura, M. (1992). Effects of intraaortic balloon pumping on coronary hemodynamics after coronary angioplasty in patients with acute myocardial infarction. American Heart Journal, 124, 1133–1138.
Papaioannou, T. G., & Stefanadis, C. (2005). Basic principles of the intraaortic balloon pump and mechanisms affecting its performance. ASAIO Journal, 51, 296–300.
Dunkman, W. B., Leinbach, R. C., Buckley, M. J., Mundth, E. D., Kantrowitz, A. R., Austen, W. G., et al. (1972). Clinical and hemodynamic results of intraaortic balloon pumping and surgery for cardiogenic shock. Circulation, 46, 465–477.
Bhayana, J. N., Scott, S. M., Sethi, G. K., & Takaro, T. (1979). Effects of intraaortic balloon pumping on organ perfusion in cardiogenic shock. Journal of Surgical Research, 26, 108–113.
Sugita, Y., Emoto, H., Morita, K., Suzuki, K., & Arai, T. (1985). The effect of intraaortic balloon pumping (IABP) on pulmonary circulation. Transactions of the American Society for Artificial Internal Organs, 31, 389–394.
Hilberman, M., Derby, G. C., Spencer, R. J., & Stinson, E. B. (1981). Effect of the intra-aortic balloon pump upon postoperative renal function in man. Critical Care Medicine, 9, 85–89.
Lawson, W. E., Hui, J. C., Zheng, Z. S., et al. (1996). Improved exercise tolerance following enhanced external counterpulsation: cardiac or peripheral effect? Cardiology, 87(4), 271–275.
Arora, R. R., Chou, T. M., Jain, D., et al. (1999). The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. Journal of the American College of Cardiology, 33(7), 1833–1840.
Werner, D., Schneider, M., Weise, M., Nonnast-Daniel, B., & Daniel, W. G. (1999). Pneumatic external counterpulsation: a new noninvasive method to improve organ perfusion. American Journal of Cardiology, 84(8), 950–952. A957-958.
Feldman, A. M., Silver, M. A., Francis, G. S., De Lame, P. A., & Parmley, W. W. (2005). Treating heart failure with enhanced external counterpulsation (EECP): design of the Prospective Evaluation of EECP in Heart Failure (PEECH) trial. Journal of Cardiac Failure, 11(3), 240–245.
Schreuder, J. J., Maisano, F., Donelli, A., et al. (2005). Beat-to-beat effects of intraaortic balloon pump timing on left ventricular performance in patients with low ejection fraction. Annals of Thoracic Surgery, 79(3), 872–880.
Meyns, B. P., Nishimura, Y., Jashari, R., Racz, R., Leunens, V. H., & Flameng, W. J. (2000). Ascending versus descending aortic balloon pumping: organ and myocardial perfusion during ischemia. Annals of Thoracic Surgery, 70, 1264–1269.
Freed, P. S., Wasfie, T., Zado, B., & Kantrowitz, A. (1988). Intraaortic balloon pumping for prolonged circulatory support. American Journal of Cardiology, 61, 554–557.
Legget, M. E., Peters, W. S., Milson, F. P., Clark, J. S., West, T. M., French, R. L., et al. (2005). Extra-aortic balloon counterpulsation. Circulation, 112(9 Suppl), I26–I31.
Jeevanandam, V., Jayakar, D., Anderson, A. S., et al. (2002). Circulatory assistance with a permanent implantable IABP: initial human experience. Circulation, 106(12 Suppl. 1), I-183–I-188.
Koenig, S. C., Spence, P. A., Pantalos, G. M., Dowling, R. D., & Litwak, K. N. (2006). Development and early testing of a simple subcutaneous counterpulsation device. ASAIO Journal, 52(4), 362–367.
Giridharan, G. A., Pantalos, G. M., Litwak, K. N., Spence, P. A., & Koenig, S. C. (2006). Predicted hemodynamic benefits of counterpulsation therapy using a superficial surgical approach. ASAIO Journal, 52(1), 39–46.
Sales, V. L., & McCarthy, P. M. (2010). Understanding the c-pulse device and its potential to treat heart failure. Current Heart Failure Reports, 7, 27–34.
Hayward, C. S., Peters, W. S., Merry, A. F., et al. (2010). Chronic extra-aortic balloon counterpulsation: first-in-human pilot study in endstage heart failure. Journal of Heart and Lung Transplantation, 29, 1427–1432.
Davies, A. N., Peters, W. S., Su, T., Sullivan, C. E., Perkidides, T., Milsom, F. P., et al. (2005). Extra-ascending aortic versus intra-descending aortic balloon counterpulsation-effect on coronary artery blood flow. Heart, Lung & Circulation, 14(3), 178–186.
Furman, S., Whitman, R., Stewart, J., Parker, B., & McMullen, M. (1971). Proximity to aortic valve and unidirectionality as prime factors in counterpulsation effectiveness. Transactions of the American Society for Artificial Internal Organs, 17, 153–159.
Conflict of Interest
I am an advanced heart failure cardiologist and manage patients with different types of mechanical circulatory support devices.
Author information
Authors and Affiliations
Corresponding author
Additional information
Associate Editor Craig Stolen oversaw the review of this article
Rights and permissions
About this article
Cite this article
Solanki, P. Aortic Counterpulsation: C-Pulse and Other Devices for Cardiac Support. J. of Cardiovasc. Trans. Res. 7, 292–300 (2014). https://doi.org/10.1007/s12265-014-9548-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-014-9548-6